Where and by whom should gastric cancer HER2/neu status be assessed?:lessons from breast cancer

Autoria(s): Salto-Tellez, Manuel; Yau, Ee Xuan; Yan, Benedict; Fox, Stephen B
Data(s)

01/06/2011
Identificador

http://pure.qub.ac.uk/portal/en/publications/where-and-by-whom-should-gastric-cancer-her2neu-status-be-assessed(18b39b3c-65a1-46b5-9586-43f8f8002088).html

http://dx.doi.org/10.1043/2011-0084-ED.1
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Salto-Tellez , M , Yau , E X , Yan , B & Fox , S B 2011 , ' Where and by whom should gastric cancer HER2/neu status be assessed? : lessons from breast cancer ' Archives of pathology & laboratory medicine , vol 135 , no. 6 , pp. 693-5 . DOI: 10.1043/2011-0084-ED.1
Palavras-Chave #Gene Expression Regulation, Neoplastic #Receptor, erbB-2 #Genes, erbB-2 #Stomach Neoplasms #Humans #In Situ Hybridization, Fluorescence #Breast Neoplasms #Tumor Markers, Biological #Immunohistochemistry #Female #DNA, Neoplasm
Tipo

article
Acesso ao item digital